Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec;29(Suppl 3):577-578.
doi: 10.1245/s10434-021-10604-y. Epub 2021 Oct 4.

ASO Author Reflections: Molecular Testing in Breast Cancer: Is Core Biopsy Equivalent to Surgical Specimen?

Javier I J Orozco  1 , Janie G Grumley  2
Affiliations
Comment

ASO Author Reflections: Molecular Testing in Breast Cancer: Is Core Biopsy Equivalent to Surgical Specimen?

Javier I J Orozco et al. Ann Surg Oncol. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest disclosures to report.

Comment on

References

    1. Sparano JA, Gray RJ, Ravdin PM, et al. Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer. N Engl J Med. 2019;380(25):2395–2405. doi: 10.1056/NEJMoa1904819. - DOI - PMC - PubMed
    1. Iwata H, Masuda N, Yamamoto Y, et al. Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study. Breast Cancer Res Treat. 2019;173(1):123–133. doi: 10.1007/s10549-018-4964-y. - DOI - PMC - PubMed
    1. Bear HD, Wan W, Robidoux A, et al. Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: a multicenter trial. J Surg Oncol. 2017;115(8):917–923. doi: 10.1002/jso.24610. - DOI - PMC - PubMed
    1. Orozco JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, Grunkemeier GL, Marzese DM, Grumley JG, et al. ASO Visual Abstract: is the 21-gene recurrence score on core needle biopsy equivalent to surgical specimen in early-stage breast cancer?: a comparison of gene expression between paired core needle biopsy and surgical specimens. Ann Surg Oncol. 2021 doi: 10.1245/s10434-021-10589-8. - DOI - PubMed
    1. Meattini I, Bicchierai G, Saieva C, et al. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature. Eur J Surg Oncol. 2017;43(4):642–648. doi: 10.1016/j.ejso.2016.10.025. - DOI - PubMed